91 related articles for article (PubMed ID: 7873283)
1. [Longitudinal analysis of glucose metabolism in recurrent meningioma].
Shioya H; Mineura K; Sasajima T; Kowada M; Iida H; Ogawa T; Hatazawa J; Uemura K
No To Shinkei; 1994 Nov; 46(11):1088-93. PubMed ID: 7873283
[TBL] [Abstract][Full Text] [Related]
2. [Hemocirculation and metabolism in intraventricular tumors: kinetic analysis of glucose metabolism].
Shioya H; Mineura K; Kowada M; Iida H; Murakami M; Ogawa T; Hatazawa J; Uemura K
No Shinkei Geka; 1996 Mar; 24(3):211-9. PubMed ID: 8851949
[TBL] [Abstract][Full Text] [Related]
3. [Kinetics of glucose metabolism in central neurocytomas].
Shioya H; Mineura K; Sasajima T; Kowada M; Iida H; Ogawa T; Hatazawa J; Uemura K
No To Shinkei; 1995 Oct; 47(10):981-7. PubMed ID: 7577144
[TBL] [Abstract][Full Text] [Related]
4. [Kinetic analysis of glucose metabolism in meningiomas--comparison with malignant gliomas].
Shioya H; Mineura K; Sasajima T; Kowada M; Iida H; Ogawa T; Hatazawa J; Uemura K
No To Shinkei; 1995 Jun; 47(6):549-56. PubMed ID: 7605682
[TBL] [Abstract][Full Text] [Related]
5. Fasting improves discrimination of grade 1 and atypical or malignant meningioma in FDG-PET.
Cremerius U; Bares R; Weis J; Sabri O; Mull M; Schröder JM; Gilsbach JM; Buell U
J Nucl Med; 1997 Jan; 38(1):26-30. PubMed ID: 8998144
[TBL] [Abstract][Full Text] [Related]
6. Kinetic analysis of glucose metabolism by FDG-PET versus proliferation index of Ki-67 in meningiomas--comparison with gliomas.
Tsuyuguchi N
Osaka City Med J; 1997 Dec; 43(2):209-23. PubMed ID: 9540343
[TBL] [Abstract][Full Text] [Related]
7. Regional kinetic constants and cerebral metabolic rate for glucose in normal human volunteers determined by dynamic positron emission tomography of [18F]-2-fluoro-2-deoxy-D-glucose.
Heiss WD; Pawlik G; Herholz K; Wagner R; Göldner H; Wienhard K
J Cereb Blood Flow Metab; 1984 Jun; 4(2):212-23. PubMed ID: 6609929
[TBL] [Abstract][Full Text] [Related]
8. Glucose utilization by intracranial meningiomas as an index of tumor aggressivity and probability of recurrence: a PET study.
Di Chiro G; Hatazawa J; Katz DA; Rizzoli HV; De Michele DJ
Radiology; 1987 Aug; 164(2):521-6. PubMed ID: 3496626
[TBL] [Abstract][Full Text] [Related]
9. [Positron emission tomography (PET) study in patients with meningiomas].
Mineura K; Sasajima T; Kowada M; Shishido F; Uemura K
No To Shinkei; 1990 Feb; 42(2):145-51. PubMed ID: 2357416
[TBL] [Abstract][Full Text] [Related]
10. Characterization of 68Ga-DOTA-D-Phe1-Tyr3-octreotide kinetics in patients with meningiomas.
Henze M; Dimitrakopoulou-Strauss A; Milker-Zabel S; Schuhmacher J; Strauss LG; Doll J; Mäcke HR; Eisenhut M; Debus J; Haberkorn U
J Nucl Med; 2005 May; 46(5):763-9. PubMed ID: 15872348
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of kinetic analysis using dynamic 18F-FDG-PET in patients with malignant primary brain tumor.
Kimura N; Yamamoto Y; Kameyama R; Hatakeyama T; Kawai N; Nishiyama Y
Nucl Med Commun; 2009 Aug; 30(8):602-9. PubMed ID: 19521265
[TBL] [Abstract][Full Text] [Related]
12. Radiation-induced meningioma evaluated with positron emission tomography with fludeoxyglucose F 18.
Kado H; Ogawa T; Hatazawa J; Iwase M; Kanno I; Okudera T; Uemura K
AJNR Am J Neuroradiol; 1996 May; 17(5):937-8. PubMed ID: 8733970
[TBL] [Abstract][Full Text] [Related]
13. In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET.
Torizuka T; Tamaki N; Inokuma T; Magata Y; Sasayama S; Yonekura Y; Tanaka A; Yamaoka Y; Yamamoto K; Konishi J
J Nucl Med; 1995 Oct; 36(10):1811-7. PubMed ID: 7562048
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of glucose metabolism in patients with esophageal cancer by PET: estimation of hexokinase activity in the tumor and usefulness for clinical assessment using 18F-fluorodeoxyglucose].
Fukunaga T; Enomoto K; Okazumi S; Kikuchi T; Yamamoto H; Koide Y; Isono K
Nihon Geka Gakkai Zasshi; 1994 May; 95(5):317-25. PubMed ID: 8007937
[TBL] [Abstract][Full Text] [Related]
15. FDG hypermetabolism associated with inflammatory necrotic changes following radiation of meningioma.
Fischman AJ; Thornton AF; Frosch MP; Swearinger B; Gonzalez RG; Alpert NM
J Nucl Med; 1997 Jul; 38(7):1027-9. PubMed ID: 9225785
[TBL] [Abstract][Full Text] [Related]
16. Glucose and methionine uptake and proliferative activity in meningiomas.
Iuchi T; Iwadate Y; Namba H; Osato K; Saeki N; Yamaura A; Uchida Y
Neurol Res; 1999 Oct; 21(7):640-4. PubMed ID: 10555183
[TBL] [Abstract][Full Text] [Related]
17. C-11 methionine and F-18 FDG uptake in a patient with meningioma and glioblastoma multiforme.
Korkmaz M; Kim EE; Wong FC; Podoloff DA
Clin Nucl Med; 1996 Jul; 21(7):580-2. PubMed ID: 8818480
[No Abstract] [Full Text] [Related]
18. [Can fluorodeoxyglucose-positron emission tomography evaluate the functional differentiation of hepatocellular carcinoma].
Enomoto K; Fukunaga T; Okazumi S; Asano T; Kikuchi T; Yamamoto H; Nagashima T; Isono K; Itoh H; Imazeki K
Kaku Igaku; 1991 Nov; 28(11):1353-6. PubMed ID: 1663176
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: characterization of tumor and assessment of effect of treatment.
Okazumi S; Isono K; Enomoto K; Kikuchi T; Ozaki M; Yamamoto H; Hayashi H; Asano T; Ryu M
J Nucl Med; 1992 Mar; 33(3):333-9. PubMed ID: 1311035
[TBL] [Abstract][Full Text] [Related]
20. Positron emission tomography elucidates transport system and tumor proliferation in meningiomas.
Murakami M; Imahori Y; Kimura S; Tatsuzawa K; Ohwada K; Inoue Y; Sasajima H; Mineura K
Oncol Rep; 2005 Oct; 14(4):853-9. PubMed ID: 16142342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]